Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992;107(1):11-7.
doi: 10.1007/BF02244959.

Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines

Affiliations
Clinical Trial

Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines

J Ingum et al. Psychopharmacology (Berl). 1992.

Abstract

In a placebo controlled, crossover study psychomotor effects of single doses of diazepam, 10 and 20 mg, flunitrazepam, 1 and 2 mg, as well as 0.9 g ethanol/kg body weight were investigated over a time period of 6 h in 12 healthy men. Blood samples were collected simultaneously with the test sessions to determine drug concentrations in plasma or blood. The ethanol dose caused the least performance impairment, followed by 10 mg diazepam. The most pronounced impairment was caused by 2 mg flunitrazepam, whereas 20 mg diazepam and 1 mg flunitrazepam caused intermediate impairment and were approximately equipotent on group level. Considerable interindividual differences with respect to maximal impairment following a particular drug treatment were observed, with poor correlation between individual maximal impairments and individual peak plasma concentrations of the drug. The maximal impairment in simple reaction time following the flunitrazepam treatments occurred earlier relative to the peak plasma concentration of the drug as compared to the diazepam treatments. This may indicate that acute tolerance develops differently for the two drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):164-8 - PubMed
    1. Psychopharmacology (Berl). 1980;70(1):89-93 - PubMed
    1. J Clin Psychopharmacol. 1986 Aug;6(4):199-209 - PubMed
    1. J Pharmacol Exp Ther. 1987 Oct;243(1):1-8 - PubMed
    1. Science. 1989 Sep 22;245(4924):1389-92 - PubMed

Publication types

LinkOut - more resources